SCLC Clinical Trials
1 recruiting
Showing 1–12 of 12 trials
Recruiting
Phase 1Phase 2
A Phase I/II Study of Sacituzumab Govitecan Plus Berzosertib in Small Cell Lung Cancer, Extra-Pulmonary Small Cell Neuroendocrine Cancer and Homologous Recombination-Deficient Cancers Resistant to PARP Inhibitors
Advanced Solid TumorsSCLCHRD Cancer
National Cancer Institute (NCI)120 enrolled1 locationNCT04826341
Recruiting
Phase 1Phase 2
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
TNBC - Triple-Negative Breast CancerAdvanced Solid TumorsNSCLC+3 more
Tubulis GmbH250 enrolled16 locationsNCT06657222
Recruiting
Phase 2
Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC
SCLC
Cancer Institute and Hospital, Chinese Academy of Medical Sciences20 enrolled2 locationsNCT07110103
Recruiting
Not Applicable
Comparing Single vs Multiple Dose Radiation for Cancer Patients With Brain Metastasis and Receiving Immunotherapy
Breast CarcinomaMelanomaNon-small Cell Lung Cancer+4 more
Wake Forest University Health Sciences244 enrolled39 locationsNCT05703269
Recruiting
Phase 1
SLV-154 Treatment of Metastatic Solid Tumors
Breast Cancer MetastaticOvarian CancerEndometrial Cancer+7 more
Solve Therapeutics70 enrolled9 locationsNCT06771219
Recruiting
Observational Study to Evaluate the Safety and Efficacy of Zepzelca™ Injection
SCLC
Boryung Pharmaceutical Co., Ltd300 enrolled1 locationNCT06021483
Recruiting
Phase 1
A Study of ZL-1310 in Subjects With Small Cell Lung Cancer
SCLC
Zai Lab (Shanghai) Co., Ltd.112 enrolled38 locationsNCT06179069
Recruiting
Phase 3
PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer
SCLC
Biotheus Inc.404 enrolled45 locationsNCT06616532
Recruiting
Cognitive Screening in Lung Cancer Patients
SCLCNSCLC (Non-small Cell Lung Cancer)Lung Disease
European Institute of Oncology200 enrolled1 locationNCT06727370
Recruiting
Phase 1
GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2
SarcomaSCLCMalignant Melanoma+1 more
Y-mAbs Therapeutics60 enrolled8 locationsNCT05130255
Recruiting
Phase 2
Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study
NSCLCSCLC
Zhejiang Provincial People's Hospital260 enrolled1 locationNCT06534762
Recruiting
Phase 2
Adebrelimab + Apatinib in SCLC Maintenance Therapy
SCLC
Tang-Du Hospital60 enrolled1 locationNCT06475209